Sofosbuvirum, Velpatasvirum, Voxilaprevirum

Medicinal product name Vosevi
Pharmaceutical form Film-coated tablet
Strength 400 mg/100 mg/100 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.II inf.)
KZS NHS Reimbursed medicines
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Conclusion on the therapeutic and cost effectiveness of medicines Nov 30, 2021 B18.2
ATC code J05AP56 Antivirals for systemic use

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28
(1 UD)
HDPE bottle 14599.80 
KZS*
EU/1/17/1223/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/17/1223/001
Date of authorisation Jul 26, 2017
Marketing authorisation holder, country Gilead Sciences Ireland UC, Ireland